Skip to main content
$579.81 $4.08 (70.9%)

12:00 PM EDT on 10/23/20

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

CAPS Rating: 4 out of 5

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

Current Price $579.81 Mkt Cap $61.0B
Open $580.29 P/E Ratio 21.28
Prev. Close $579.81 Div. (Yield) $0.00 (0.0%)
Daily Range $575.12 - $582.72 Volume 565,966
52-Wk Range $303.22 - $664.64 Avg. Daily Vol. 1,007,280

Caps

How do you think NASDAQ:REGN will perform against the market?

Add Stock to CAPS Watchlist

All Players

403 Outperform
72 Underperform
 

All-Star Players

98 Outperform
11 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:REGN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Morass (< 20)
Submitted September 07, 2014

REGN has a pipeline of potential biotech products.

PDTBiotech (67.56)
Submitted February 25, 2012

$9.7B? Lots of obstacles, including Lucentis, Avastin, payers, etc., and the market is acting like they've already hit huge numbers. Strange self-limiting value prop on this, they had to develop it based on decreased injection frequency rather than… More

NASDAQ:REGN VS S&P 500 (SPY)

Fools bullish on NASDAQ:REGN are also bullish on:

Fools bearish on NASDAQ:REGN are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about REGN.

Recs

0
Member Avatar cantare226 (< 20) Submitted: 8/17/2020 12:12:14 PM : Outperform Start Price: $624.78 NASDAQ:REGN Score: -9.42

Great pipeline plus potential COVID boost.

Recs

0
Member Avatar MiningForProfit (44.77) Submitted: 7/15/2020 8:01:02 AM : Outperform Start Price: $615.58 NASDAQ:REGN Score: -12.96

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions.

Recs

0
Member Avatar JaxPicks (64.28) Submitted: 4/23/2020 12:07:16 PM : Outperform Start Price: $569.78 NASDAQ:REGN Score: -20.48

Pharma co. with good growth at reasonable p/e with high GM and ROIC.

Leaderboard

Find the members with the highest scoring picks in REGN.

Score Leader

oneisthelonelies

oneisthelonelies (< 20) Score: +3,849.78

The Score Leader is the player with the highest score across all their picks in REGN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
oneisthelonelies < 20 8/6/2007 Outperform 5Y $14.15 +4,002.19% +152.41% +3,849.78 0 Comment
DNAdivaSTL 46.57 7/8/2008 Outperform NS $14.30 +3,959.16% +185.30% +3,773.86 0 Comment
Grinnell4Eva < 20 6/6/2008 Outperform 1Y $14.88 +3,800.94% +162.21% +3,638.73 0 Comment
kiranmn < 20 5/27/2009 Outperform 3Y $14.49 +3,905.94% +282.11% +3,623.82 0 Comment
stlb1ues 61.17 6/26/2008 Outperform 1Y $14.96 +3,780.08% +173.26% +3,606.82 0 Comment
giffman62 < 20 6/6/2008 Outperform NS $15.22 +3,713.80% +155.39% +3,558.41 1 Comment
Pmccorm 93.99 6/5/2008 Outperform 3Y $15.28 +3,698.82% +156.82% +3,542.01 0 Comment
benes27 70.41 6/5/2008 Outperform 3M $15.28 +3,698.82% +156.87% +3,541.95 0 Comment
mpearson29 76.18 11/25/2008 Outperform NS $14.74 +3,837.99% +306.05% +3,531.94 0 Comment
UncleSmitty 52.62 7/14/2008 Outperform NS $15.24 +3,708.79% +184.55% +3,524.24 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for REGN.